COVID-19 | Disease | FDA | Therapeutics
City of Hope doctors lead novel clinical trial to treat cancer patients with COVID-19
On Sept. 1, 2020, City of Hope announced that it was investigating an innovative treatment for cancer patients…
Sanofi updated Kevzara (sarilumab) phase 3 trial in severe and critically ill COVID-19 patients outside the US
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…
HDT BIO received NIH contract to advance novel RNA/LIONﾙ COVID-19 vaccine into clinical trials
On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…
Atossa Therapeutics announced positive safety assessment in clinical study of COVID-19 AT-301 nasal spray
On Sept. 1, 2020, Atossa Therapeutics announced a positive interim safety assessment from the first cohort of healthy…
National Wastewater Surveillance System launched to detect antimicrobial resistance and COVID-19
In September 2020, the Centers for Disease Control and Prevention (CDC) announced the launch of the National Wastewater…
Scientists used genomics to discover an ancient dog species that may teach us about human vocalization
On Aug. 31, 2020, in a study published in PNAS, researchers used conservation biology and genomics to discover…
Phase 3 clinical testing in the US of AstraZeneca COVID-19 vaccine candidate began
On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…
Development of COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial across all adult age groups
On Aug. 31, 2020, AstraZeneca announced that the COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial…
Biotechnology | Diagnostics | Disease | NIH
New gene associated with reduced risk for cirrhosis
On Aug. 31, 2020, an international team of scientists supported by the National Institutes of Health (NIH) announced…
Vir Biotechnology and GSK started phase 2/3 study of COVID-19 antibody treatment
On Aug. 31, 2020, Vir Biotechnology and GlaxoSmithKline announced that the first patient was dosed in a phase…
Philips EV300 ventilator supply contract with US Department of Health and Human Services to end
On Aug. 31, 2020, Royal Philips announced that it had received notice from the U.S. Department of Health…
UConn launched funding program for COVID-19 research
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
T2 Biosystems received FDA Emergency Use Authorization for COVID-19 molecular diagnostic test
On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…
Novavax and Canada reached agreement to acquire Novavax COVID-19 vaccine
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
Disease | NIH | Therapeutics
NIAID awarded BioCryst $44 million contract to advance development of galidesivir
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratory
On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
FDA expanded Emergency Use Authorization for Veklury (remdesivir) to include all hospitalized patients for treatment of COVID-19
On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
The US Dept of Veterans Affairs anounced new clinical trial for Veterans with COVID-19
On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…
Gileadﾒs investigational antiviral Vekluryﾮ (remdesivir) received FDA Emergency Use Authorization for treatment of patients with moderate COVID-19
On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…
Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer research
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
NIH established Centers for Research in Emerging Infectious Diseases
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
RedHill Biopharma Announced Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
On Aug. 27, 2020, RedHill Biopharma announced that its U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in…
Vaccitech received government grant for COVID-19 vaccine research
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
International research alliance launched to boost pandemic preparedness
On Aug. 27, 2020, scientists at Scripps Research announced they were partnering with peers in the U.S. and…
AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model
On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…
Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19
On Aug. 27, 2020, Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19 from our CLIA-certified laboratory….
Todos Medical announced $4,500,000 contract for COVID-19 PCR testing equipment & supplies with New York-based laboratory
On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…
BioNTech and Fosun Pharma to potentially supply 10 Million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV-2
On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…